01 1Hetero Drugs
01 1RITONAVIR USP (FORM I), PROCESS II
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-05-01
Pay. Date : 2013-01-07
DMF Number : 24629
Submission : 2011-02-11
Status : Active
Type : II
20
Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RITONAVIR USP (FORM I), PROCESS II, with a corresponding US DMF Number 24629.
Remarkably, this DMF maintains an Active status since its submission on February 11, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 01, 2013, and payment made on January 07, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
